CytoMed Therapeutics Limited (GDTC) Ownership
GDTC ownership summary
as of October 17, 2026- Institutions
- 0.1% of shares outstanding
- Insiders
- 70.49% of shares outstanding
- Shares outstanding
- 11.9M
- Float
- 3.5M shares available to trade
- Short interest
- 0.48% 17K shares short
- Days to cover
- 1.26 short interest up 372.4% vs prior month
- Institutions 0.14%
- Insiders 70.49%
- Other investors 29.37%
GDTC top institutional holders
5 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Axiom Investment Management LLC | 0.06% | 7,032 | $6,188 | +7,032 (0.0%) | June 30, 2026 |
| 2 | UBS Group AG | 0.04% | 4,831 | $4,251 | −1,351 (−21.9%) | June 30, 2026 |
| 3 | Advisor Group Holdings, Inc. | <0.01% | 21 | $18 | — | June 30, 2026 |
| 4 | StoneX Group Inc | 0.00% | — | — | −10,356 (−100.0%) | March 31, 2026 |
| 5 | XTX Topco Ltd | 0.00% | — | — | −10,136 (−100.0%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 5, 1 holders added 7,032 shares and 3 cut 22K.
GDTC top mutual fund and ETF holders
1 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Fidelity Nasdaq Composite Index | 0.04% | 4,854 | $4,272 | — | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
GDTC shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns GDTC
Institutional investors own 0.1% of CytoMed Therapeutics's shares and insiders 70.49%. The largest holder is Axiom Investment Management LLC with 0.06% of the shares (7,032), as of June 30, 2026. Among the top 5 institutions, 1 added shares and 3 reduced their stake in the latest filings. Short interest is 0.48% of the float, or 1.26 days of average trading volume. The share count rose 97.8% since 2020.
Related: GDTC analyst forecast, GDTC key metrics. See the GDTC stock overview for the latest quote and news.
GDTC ownership FAQ
Who owns the most CytoMed Therapeutics stock?
The largest shareholders of CytoMed Therapeutics are Axiom Investment Management LLC (0.06%), UBS Group AG (0.04%), Advisor Group Holdings, Inc. (<0.01%), StoneX Group Inc (0.00%), XTX Topco Ltd (0.00%).
What percentage of CytoMed Therapeutics is owned by institutions?
Institutions hold 0.1% of CytoMed Therapeutics's shares outstanding; insiders hold 70.49%.
Which funds own CytoMed Therapeutics?
The largest fund holders of CytoMed Therapeutics are Fidelity Nasdaq Composite Index (0.04%).
What is CytoMed Therapeutics's short interest?
17K shares of CytoMed Therapeutics were sold short, 0.48% of the float; at the average daily volume it would take 1.26 days to cover.
How many shares of CytoMed Therapeutics are outstanding?
CytoMed Therapeutics has 11.9M shares outstanding, of which 3.5M are in the public float.